Analysis on the Correlation Between RUNX3 Mislocalization and Epigenetic Parameters in Non-Small Cell Lung Cancer

被引：0
|
作者：
Liu, W. [1 ,2 ]
Huang, C. [1 ,3 ]
Shi, Y. [4 ,5 ]
Lu, J. [4 ]
Chen, X. [1 ,2 ,5 ]
机构：
[1] Fujian Med Univ, Grad Sch, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Dept Thorac Surg, Fujian Canc Hosp, Clin Oncol Sch, Fuzhou, Fujian, Peoples R China
[3] Fujian Med Univ, Clin Oncol Sch, Lab Immunooncol, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[4] Fujian Med Univ, Dept Pathol, Clin Oncol Sch, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[5] Fuzhou Univ, Interdisciplinary Inst Med Engn, Fuzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
runt-related transcription factor 3; promoter hypermethylation; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.02B.06
引用
收藏
页码：S438 / S439
页数：2
相关论文
共 50 条
  • [1] Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer
    Chen, Xiaohui
    Deng, Yujie
    Shi, Yi
    Zhu, Weifeng
    Cai, Yibin
    Xu, Chunwei
    Zhu, Kunshou
    Zheng, Xiongwei
    Chen, Gang
    Xie, Qi
    Weng, Guoxing
    ONCOLOGY LETTERS, 2018, 15 (04) : 5043 - 5055
  • [2] Loss of Expression Rather Than Cytoplasmic Mislocalization of RUNX3 Predicts Worse Outcome in Non-Small Cell Lung Cancer
    Chen, X.
    Deng, Y.
    Shi, Y.
    Zhu, W.
    Zhu, K.
    Zheng, X.
    Lin, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S725 - S726
  • [3] Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer
    Yu, Gui-Ping
    Ji, Yong
    Chen, Guo-Qiang
    Huang, Bin
    Shen, Kai
    Wu, Song
    Shen, Zhen-Ya
    ONCOLOGY LETTERS, 2012, 3 (01) : 159 - 162
  • [4] Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
    Xu, Lijun
    Lan, Hongwen
    Su, Yushu
    Li, Jun
    Wan, Jingwen
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2855 - 2865
  • [5] MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3
    Wang, Yu
    Li, Yuqiang
    Wu, Bin
    Shi, Ce
    Li, Chen
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 2113 - 2120
  • [6] The correlation between hemostatic parameters and mortality rate in patients with non-small cell lung cancer
    Soeroso, Noni Novisari
    Ananda, Fannie Rizki
    Samosir, Ganda
    Hariman, Herman
    Eyanoer, Putri Chairani
    HEMATOLOGY REPORTS, 2021, 13 (03)
  • [7] Correlation between survivin expression and prognosis in non-small cell lung cancer
    Atikcan, Sukran
    Unsal, Ebru
    Demirag, Funda
    Koksal, Deniz
    Yilmaz, Aydin
    RESPIRATORY MEDICINE, 2006, 100 (12) : 2220 - 2226
  • [8] Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays
    Dmitriev, Alexey A.
    Kashuba, Vladimir I.
    Haraldson, Klas
    Senchenko, Vera N.
    Pavlova, Tatiana V.
    Kudryavtseva, Anna V.
    Anedchenko, Ekaterina A.
    Krasnov, George S.
    Pronina, Irina V.
    Loginov, Vitalij I.
    Kondratieva, Tatiana T.
    Kazubskaya, Tatiana P.
    Braga, Eleonora A.
    Yenamandra, Surya P.
    Ignatjev, Ilya
    Ernberg, Ingemar
    Klein, George
    Lerman, Michael I.
    Zabarovsky, Eugene R.
    EPIGENETICS, 2012, 7 (05) : 502 - 513
  • [9] Hsa-miR-301a-3p inhibited the killing effect of natural killer cells on non-small cell lung cancer cells by regulating RUNX3
    Zhang, Junkai
    Yang, Yingyu
    Wei, Ying
    Li, Lamei
    Wang, Xinyi
    Ye, Zhihua
    CANCER BIOMARKERS, 2023, 37 (04) : 249 - 259
  • [10] CORRELATION OF SNAIL AND LYMPHOCYTE ACTIVATION GENE-3 WITH CLINICOPATHOLOGICAL PARAMETERS AND PROGNOSIS IN NON-SMALL CELL LUNG CANCER
    Su, Ling
    Tang, Hua
    Bao, Hong
    ACTA MEDICA MEDITERRANEA, 2020, 36 (01): : 551 - 556
12345